Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T Cell Lymphomas; Evidence of Graft-Versus-T Cell Lymphoma Effect

14 Mar 2008

Abstract excerpt

T cell non-Hodgkin lymphomas (TNHL) are an uncommon and heterogeneous group of lymphoid malignancies characterized by a poor prognosis. They usually present with advanced-stage disease and high International Prognostic Index (IPI) score [1]. Patients with TNHL treated with conventional-dose chemotherapy alone in general have inferior overall survival (OS) and event-free survival compared to those with diffuse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphoma Diagnosis and Treatment
Share to T-cell and Retrovirus Studies
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18342792
DOI: 10.1016/j.bbmt.2008.01.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T Cell Lymphomas; Evidence of Graft-Versus-T Cell Lymphoma EffectPMID 18342792Read ↗

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin LymphomaSemantic proximity Read ↗

Ofatumumab as Part of Reduced Intensity Conditioning in High Risk B-cell Lymphoma Patients: Final Long-term Analysis From a Prospective Multicenter Phase-ii TrialSemantic proximity Read ↗

Hematopoietic Cell Transplantation for LymphomasSemantic proximity Read ↗

Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in JapanSemantic proximity Read ↗

Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplantSemantic proximity Read ↗

What is the role of autologous transplant for lymphoma in the current era?Semantic proximity Read ↗

First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantationSemantic proximity Read ↗

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donorsSemantic proximity Read ↗

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies.Semantic proximity Read ↗

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplantSemantic proximity Read ↗

Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with LymphomaSemantic proximity Read ↗

BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation FeasibilitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.